The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 13, 2016
Filed:
Apr. 10, 2006
Applicants:
Anne Jessica Gorman, Hightstown, NJ (US);
Sanyog Manohar Pendharkar, Edison, NJ (US);
Guanghui Zhang, Belle Mead, NJ (US);
Liliana Bar, Rehovot, IL;
Israel Nur, Moshav Timorim, IL;
Roberto Meidler, Holon, IL;
Inventors:
Anne Jessica Gorman, Hightstown, NJ (US);
Sanyog Manohar Pendharkar, Edison, NJ (US);
Guanghui Zhang, Belle Mead, NJ (US);
Liliana Bar, Rehovot, IL;
Israel Nur, Moshav Timorim, IL;
Roberto Meidler, Holon, IL;
Assignees:
Ethicon, Inc., Somerville, NJ (US);
Omrix Biopharmaceutical, Inc., Rhode-St-Genese, BE;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 15/00 (2006.01); A61L 15/26 (2006.01); A61L 15/28 (2006.01); A61L 15/32 (2006.01); A61L 15/44 (2006.01); A61L 15/64 (2006.01); B32B 5/02 (2006.01); B32B 5/26 (2006.01); B32B 23/02 (2006.01); B32B 23/10 (2006.01); B32B 27/36 (2006.01);
U.S. Cl.
CPC ...
A61L 15/26 (2013.01); A61L 15/28 (2013.01); A61L 15/32 (2013.01); A61L 15/44 (2013.01); A61L 15/64 (2013.01); B32B 5/022 (2013.01); B32B 5/024 (2013.01); B32B 5/026 (2013.01); B32B 5/26 (2013.01); B32B 23/02 (2013.01); B32B 23/10 (2013.01); B32B 27/36 (2013.01); A61L 2300/418 (2013.01); A61L 2300/608 (2013.01); A61L 2400/04 (2013.01); B32B 2250/20 (2013.01); B32B 2262/0276 (2013.01); B32B 2262/06 (2013.01); B32B 2262/062 (2013.01); B32B 2307/726 (2013.01); B32B 2556/00 (2013.01); Y10T 442/2525 (2015.04);
Abstract
The present invention is directed to a reinforced absorbable multilayered hemostatic wound dressing comprising a first absorbable nonwoven fabric, a second absorbable woven or knitted fabric, thrombin and/or fibrinogen.